Diabetes, an increasingly prevalent metabolic disorder, causes high blood glucose levels caused by decreased insulin secretion, action, or both. WHO reports say that in 2021, diabetes ranked among the top ten global causes of death, having experienced a substantial growth of 95% since 2000. Comprehensive therapies are essential for diabetic patients to enhance their quality of life and mitigate the onset of chronic problems. Trace elements, or microelements, are essential for growth, development, and metabolism. Recently, metallic nanoparticles have gained great interest as antidiabetic nanomedicines, regulating glucose metabolism and showing potential for diabetes management. “Phytomediated green synthesis of nanoparticles” is gaining popularity due to its cost-effectiveness and eco-friendliness. This chapter covers the mechanisms of action, association with diabetes, and therapeutic potential of phytomediated nanoparticles. It discusses the pathogenesis, current therapeutic landscape, and physiological impacts of nanoparticles. We delved into a variety of phytomediated nanoparticles through green synthesis using various parts of source plants, specifically those derived from Ag, Mg, Au, Cr, Se, Zn, Fe, and Cu. Additionally, we give instances of evidence-based practice, such as the “green synthesis of silver nanoparticles (AgNPs)” from Tephrosia tinctoria extract produces AgNPs with more flavonoids and phenolics. Bioactive compounds capping AgNPs include “flavonoids, glycosides, phenols, tannins, alkaloids, saponins, terpenoids and coumarins.” This chapter explores how these nanoparticles may successfully combat diabetes by: enhancing insulin secretion, mitigating glucose intolerance, lowering blood glucose levels, optimizing lipid profiles, improving insulin sensitivity, and exhibiting anti-inflammatory and antioxidant properties, among other processes. The chapter concludes that phytomediated nanoparticles can serve as dietary modifiers or nanomedicines for efficient diabetes therapy.